Lab
South Bend Medical Foundation, INC
South Bend Medical Foundation, INC was paid $5.78M by Medicaid between Jan 2018 and Nov 2024, across 247 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 24% of everything it billed.
33Billing provider infoSOUTH BEND MEDICAL FOUNDATION, INC
SOUTH BEND, IN 46635
SOUTH BEND, IN 46635
33aNPI1649241084assigned 02/01/2006
33bProvider typeClinical Medical Laboratory
28Total paid$5.78M
24GClaims486,541
24DCodes billed247
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Indiana
Rank by total paid#6 of 66
Median peer was paid$53K
This provider vs. median110×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 261,696 | $1.75M | |
| 2019 | 176,958 | $2.39M | |
| 2020 | 13,158 | $423K | |
| 2021 | 5,939 | $276K | |
| 2022 | 7,506 | $289K | |
| 2023 | 13,412 | $338K | |
| 2024incomplete | 7,872 | $313K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 24% | 42,065 | 31,981 | $1.41M |
| 88307 | 6.9% | 7,614 | 6,136 | $401K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.5% | 12,602 | 11,537 | $260K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.5% | 12,546 | 11,484 | $259K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4.4% | 6,006 | 5,096 | $254K |
| 80050 | General health panel | 3.5% | 5,881 | 5,259 | $201K |
| 80053 | Comprehensive metabolic panel | 2.2% | 27,191 | 21,599 | $127K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.0% | 6,966 | 6,202 | $116K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.9% | 29,900 | 22,049 | $110K |
| 88341 | 1.8% | 3,091 | 2,031 | $107K | |
| 80061 | Lipid panel | 1.8% | 14,972 | 13,515 | $107K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.8% | 13,057 | 11,831 | $103K |
235 more codes
| 87653 | 1.7% | 3,710 | $96K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1.7% | 8,441 | $96K |
| 88342 | 1.7% | 4,629 | $96K | |
| 88304 | 1.6% | 9,066 | $91K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.5% | 5,041 | $89K |
| 86003 | 1.5% | 1,235 | $87K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 1.4% | 4,304 | $79K |
| 83655 | 1.1% | 5,641 | $62K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 9,556 | $48K |
| 36415 | Collection of venous blood by venipuncture | <1% | 42,464 | $48K |
| 87536 | <1% | 831 | $46K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 8,894 | $45K |
| 80074 | <1% | 1,568 | $44K | |
| 80055 | <1% | 1,380 | $42K | |
| 85027 | <1% | 9,418 | $36K | |
| 88112 | <1% | 3,196 | $34K | |
| 86481 | <1% | 499 | $31K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 2,129 | $31K |
| 88312 | <1% | 1,651 | $30K | |
| 87081 | <1% | 5,574 | $30K | |
| 86780 | <1% | 3,081 | $29K | |
| 84439 | <1% | 5,194 | $28K | |
| 86762 | <1% | 2,600 | $27K | |
| 82728 | <1% | 3,283 | $25K | |
| 86360 | <1% | 773 | $24K | |
| 83516 | <1% | 953 | $24K | |
| 83970 | <1% | 1,483 | $24K | |
| 88302 | <1% | 2,614 | $23K | |
| 87631 | <1% | 176 | $22K | |
| 87522 | Neg quan hep c or qual rna | <1% | 759 | $22K |
| 86359 | <1% | 784 | $20K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 737 | $20K |
| 86480 | <1% | 557 | $19K | |
| 87186 | <1% | 3,467 | $19K | |
| 87340 | <1% | 3,407 | $19K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,989 | $19K |
| 84403 | <1% | 1,181 | $19K | |
| 82607 | <1% | 2,477 | $18K | |
| 84702 | <1% | 2,523 | $18K | |
| 82677 | <1% | 850 | $17K | |
| 82105 | <1% | 1,361 | $16K | |
| 86334 | <1% | 2,910 | $16K | |
| 88141 | <1% | 1,302 | $15K | |
| 88360 | <1% | 391 | $15K | |
| 84153 | <1% | 1,601 | $15K | |
| 87077 | <1% | 2,265 | $14K | |
| 87088 | <1% | 2,577 | $14K | |
| 84481 | <1% | 1,391 | $14K | |
| 82570 | <1% | 5,332 | $13K | |
| 83550 | <1% | 2,873 | $13K | |
| 86803 | <1% | 1,345 | $13K | |
| 86038 | <1% | 1,807 | $13K | |
| 86850 | <1% | 3,363 | $12K | |
| 86235 | <1% | 180 | $12K | |
| 83735 | <1% | 4,103 | $12K | |
| 83020 | <1% | 1,057 | $11K | |
| 82950 | <1% | 3,047 | $11K | |
| 88173 | <1% | 301 | $11K | |
| 82784 | <1% | 1,067 | $11K | |
| 88313 | <1% | 741 | $11K | |
| 86336 | <1% | 839 | $11K | |
| 81001 | <1% | 6,442 | $11K | |
| 83540 | <1% | 3,073 | $10K | |
| 86255 | <1% | 967 | $10K | |
| 85060 | <1% | 1,158 | $10K | |
| 86696 | <1% | 392 | $10K | |
| 82785 | <1% | 586 | $9K | |
| 86787 | <1% | 939 | $9K | |
| 84146 | <1% | 702 | $9K | |
| 80164 | <1% | 1,036 | $9K | |
| 84165 | <1% | 3,398 | $9K | |
| 88189 | <1% | 315 | $9K | |
| 82670 | <1% | 434 | $8K | |
| 82652 | <1% | 358 | $8K | |
| 82746 | <1% | 1,011 | $7K | |
| 80177 | <1% | 735 | $7K | |
| 80069 | <1% | 1,993 | $7K | |
| 85610 | <1% | 4,134 | $7K | |
| 83001 | <1% | 627 | $7K | |
| 86376 | <1% | 633 | $7K | |
| 87070 | <1% | 1,245 | $7K | |
| 82043 | <1% | 2,477 | $7K | |
| 86901 | <1% | 3,167 | $7K | |
| 83880 | <1% | 487 | $6K | |
| 86900 | <1% | 3,052 | $6K | |
| 88311 | <1% | 1,521 | $6K | |
| 86140 | <1% | 2,214 | $6K | |
| 83525 | <1% | 703 | $6K | |
| 84156 | <1% | 3,395 | $6K | |
| 87449 | <1% | 584 | $6K | |
| 83883 | <1% | 453 | $5K | |
| 82951 | <1% | 508 | $5K | |
| 86695 | <1% | 342 | $5K | |
| 80175 | <1% | 475 | $5K | |
| 80197 | <1% | 941 | $5K | |
| 87147 | <1% | 617 | $4K | |
| 82248 | <1% | 1,086 | $4K | |
| 87510 | <1% | 603 | $4K | |
| 87480 | <1% | 603 | $4K | |
| 87660 | <1% | 603 | $4K | |
| 85652 | <1% | 2,751 | $4K | |
| 86800 | <1% | 351 | $4K | |
| 86592 | <1% | 1,335 | $4K | |
| 83002 | <1% | 269 | $4K | |
| 80183 | <1% | 323 | $4K | |
| 80076 | <1% | 963 | $4K | |
| 86160 | <1% | 219 | $4K | |
| 87205 | <1% | 1,389 | $4K | |
| 83921 | <1% | 250 | $4K | |
| 84550 | <1% | 1,357 | $4K | |
| 82378 | <1% | 386 | $4K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 47 | $3K |
| 87902 | <1% | 14 | $3K | |
| 84460 | <1% | 1,054 | $3K | |
| 82747 | <1% | 427 | $3K | |
| 82668 | <1% | 296 | $3K | |
| 87427 | <1% | 360 | $3K | |
| 87329 | <1% | 358 | $3K | |
| 82550 | <1% | 1,251 | $3K | |
| 85660 | <1% | 611 | $3K | |
| 84450 | <1% | 966 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 132 | $3K |
| 82247 | <1% | 693 | $3K | |
| 84100 | <1% | 1,691 | $3K | |
| 87328 | <1% | 307 | $3K | |
| 82140 | <1% | 412 | $3K | |
| 84144 | <1% | 249 | $3K | |
| 87529 | <1% | 92 | $3K | |
| 86706 | <1% | 359 | $3K | |
| 83615 | <1% | 811 | $3K | |
| 86431 | <1% | 796 | $3K | |
| 87046 | <1% | 361 | $3K | |
| 87045 | <1% | 359 | $3K | |
| 86304 | <1% | 224 | $3K | |
| 86300 | <1% | 147 | $3K | |
| 82565 | <1% | 954 | $2K | |
| 84166 | <1% | 497 | $2K | |
| 82024 | <1% | 72 | $2K | |
| 84402 | <1% | 109 | $2K | |
| 87808 | <1% | 178 | $2K | |
| 80178 | <1% | 654 | $2K | |
| 87338 | <1% | 166 | $2K | |
| 87493 | <1% | 98 | $2K | |
| 85730 | <1% | 500 | $2K | |
| 83013 | <1% | 30 | $2K | |
| 88331 | <1% | 62 | $2K | |
| 86335 | <1% | 237 | $2K | |
| 85097 | <1% | 64 | $2K | |
| 82533 | <1% | 139 | $2K | |
| 83690 | <1% | 695 | $2K | |
| 82150 | <1% | 434 | $2K | |
| 82977 | <1% | 324 | $2K | |
| 87324 | <1% | 204 | $2K | |
| 84270 | <1% | 97 | $1K | |
| 84155 | <1% | 807 | $1K | |
| 85018 | <1% | 939 | $1K | |
| 86200 | <1% | 193 | $1K | |
| 84703 | <1% | 380 | $1K | |
| 85014 | <1% | 874 | $1K | |
| 85045 | <1% | 463 | $1K | |
| 84520 | <1% | 660 | $1K | |
| 86618 | <1% | 123 | $1K | |
| 80081 | <1% | 15 | $1K | |
| 82952 | <1% | 365 | $1K | |
| 82627 | <1% | 49 | $1K | |
| 82310 | <1% | 451 | $1K | |
| 82164 | <1% | 71 | $1K | |
| 82947 | <1% | 430 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 59 | $957.84 |
| 83090 | <1% | 92 | $910.23 | |
| 85379 | <1% | 174 | $893.91 | |
| 86606 | <1% | 29 | $812.86 | |
| 86765 | <1% | 67 | $739.30 | |
| 84305 | <1% | 39 | $731.01 | |
| 88108 | <1% | 46 | $727.21 | |
| 80359 | <1% | 255 | $687.04 | |
| 80325 | <1% | 188 | $679.65 | |
| 82664 | <1% | 28 | $664.05 | |
| 86039 | <1% | 64 | $626.72 | |
| 86147 | <1% | 14 | $576.07 | |
| 84207 | <1% | 26 | $575.49 | |
| 87799 | <1% | 58 | $564.18 | |
| 86225 | <1% | 37 | $492.63 | |
| 85613 | <1% | 69 | $476.96 | |
| 82330 | <1% | 82 | $473.57 | |
| 82274 | <1% | 28 | $459.17 | |
| 83721 | <1% | 125 | $448.76 | |
| 84075 | <1% | 218 | $429.20 | |
| 84436 | <1% | 76 | $415.27 | |
| 85705 | <1% | 56 | $393.96 | |
| 87075 | <1% | 87 | $381.62 | |
| 85306 | <1% | 26 | $361.07 | |
| 83630 | <1% | 26 | $355.69 | |
| 83520 | <1% | 45 | $345.40 | |
| 80356 | <1% | 227 | $334.16 | |
| 80365 | <1% | 228 | $334.16 | |
| 80361 | <1% | 228 | $334.16 | |
| 84134 | <1% | 78 | $328.53 | |
| 80201 | <1% | 31 | $266.56 | |
| 88142 | <1% | 13 | $262.06 | |
| 87206 | <1% | 70 | $257.34 | |
| 83010 | <1% | 29 | $240.70 | |
| 84132 | <1% | 188 | $235.57 | |
| 87040 | <1% | 38 | $201.42 | |
| 82040 | <1% | 179 | $190.49 | |
| 84630 | <1% | 42 | $186.66 | |
| 86141 | <1% | 16 | $181.74 | |
| 80185 | <1% | 46 | $174.01 | |
| 84295 | <1% | 126 | $166.00 | |
| 80051 | <1% | 43 | $159.49 | |
| 85300 | <1% | 14 | $152.06 | |
| 82103 | <1% | 13 | $145.52 | |
| 80156 | <1% | 35 | $144.78 | |
| 86735 | <1% | 12 | $140.68 | |
| 84681 | <1% | 12 | $137.45 | |
| 80184 | <1% | 15 | $122.68 | |
| 87102 | <1% | 22 | $111.98 | |
| 83993 | <1% | 12 | $92.36 | |
| 82374 | <1% | 113 | $81.23 | |
| 82435 | <1% | 113 | $80.88 | |
| 80047 | <1% | 31 | $78.28 | |
| 87210 | <1% | 42 | $78.13 | |
| 86308 | <1% | 12 | $72.42 | |
| 80195 | <1% | 21 | $50.88 | |
| 81015 | <1% | 18 | $20.37 | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 520 | $0.65 |
| G0475 | Hiv antigen/antibody, combination assay, screening | 0% | 25 | $0.00 |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 0% | 118 | $0.00 |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 0% | 173 | $0.00 |
| 0065U | 0% | 657 | $0.00 | |
| 87428 | 0% | 35 | $0.00 | |
| 87797 | 0% | 26 | $0.00 | |
| 80324 | 0% | 53 | $0.00 | |
| 81025 | 0% | 26 | $0.00 | |
| 86008 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPIPP, TERRY (CFO)
| Provider | Location | Paid |
|---|---|---|
| South Bend Medical Foundation, INC | South Bend, IN | $301K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.